From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: I shall make this simple - how close to insolvency is Cabot & are its ex CEO and FD insider dealers?

By Tom Winnifrith | Monday 23 July 2018


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


You have less than a week of me berating you but as we celebrate Optibiotix (OPTI) reaching 100p ( twice) today I ask you to spare a tenner for a great cause. We are more than 80% of the way to hitting our £20,000 walk for Woodlarks target so ahead of 32 miles of pain for myself, Brokerman Dan & Lucian Miers please donate HERE. Elsewhere I look at IQE (IQE), Frontera (FRR), SalvarX (SALV), Pantheon Resources (PANR), Golden Prospect Precious Metals (GPPM) and finally what may be a major scandal at Cabot Energy (CAB).

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:38:54